FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386779223> ?p ?o ?g. }

• W4386779223 endingPage "105009" @default.
• W4386779223 startingPage "105009" @default.
• W4386779223 abstract "Hypogammaglobulinemia is characterized by reduced serum immunoglobulin levels. Secondary hypogammaglobulinemia is of considerable interest to the practicing physician because it is a potential complication of some medications and may predispose patients to serious infections. Patients with multiple sclerosis (MS) treated with B-cell–depleting anti-CD20 therapies are particularly at risk of developing hypogammaglobulinemia. Among these patients, hypogammaglobulinemia has been associated with an increased risk of infections. The mechanism by which hypogammaglobulinemia arises with anti-CD20 therapies (ocrelizumab, ofatumumab, ublituximab, rituximab) remains unclear and does not appear to be simply due to the reduction in circulating B-cell levels. Further, despite the association between anti-CD20 therapies, hypogammaglobulinemia, and infections, there is currently no generally accepted monitoring and treatment approach among clinicians treating patients with MS. Here, we review the literature and discuss possible mechanisms of secondary hypogammaglobulinemia in patients with MS, hypogammaglobulinemia results in MS anti-CD20 therapy clinical trials, the risk of infection for patients with hypogammaglobulinemia, and possible strategies for disease management. We also include a suggested best-practice approach to specifically address secondary hypogammaglobulinemia in patients with MS treated with anti-CD20 therapies." @default.
• W4386779223 created "2023-09-16" @default.
• W4386779223 creator A5033878767 @default.
• W4386779223 creator A5049696879 @default.
• W4386779223 creator A5064205043 @default.
• W4386779223 creator A5071983698 @default.
• W4386779223 creator A5087151734 @default.
• W4386779223 date "2023-11-01" @default.
• W4386779223 modified "2023-10-18" @default.
• W4386779223 title "Secondary hypogammaglobulinemia in patients with multiple sclerosis on anti-CD20 therapy: pathogenesis, risk of infection, and disease management" @default.
• W4386779223 cites W1203865291 @default.
• W4386779223 cites W1585164707 @default.
• W4386779223 cites W1851436333 @default.
• W4386779223 cites W1963778872 @default.
• W4386779223 cites W1967360492 @default.
• W4386779223 cites W1981480907 @default.
• W4386779223 cites W1982021670 @default.
• W4386779223 cites W2013176883 @default.
• W4386779223 cites W2015475303 @default.
• W4386779223 cites W2019651104 @default.
• W4386779223 cites W2035017743 @default.
• W4386779223 cites W2078991012 @default.
• W4386779223 cites W2104413012 @default.
• W4386779223 cites W2105421015 @default.
• W4386779223 cites W2128600935 @default.
• W4386779223 cites W2141111992 @default.
• W4386779223 cites W2483097488 @default.
• W4386779223 cites W2514636267 @default.
• W4386779223 cites W2536452417 @default.
• W4386779223 cites W2561881161 @default.
• W4386779223 cites W2565433170 @default.
• W4386779223 cites W2565757318 @default.
• W4386779223 cites W2622879993 @default.
• W4386779223 cites W2736882042 @default.
• W4386779223 cites W2754974614 @default.
• W4386779223 cites W2770486162 @default.
• W4386779223 cites W2800924304 @default.
• W4386779223 cites W2801235164 @default.
• W4386779223 cites W2889885328 @default.
• W4386779223 cites W2895499319 @default.
• W4386779223 cites W2896294018 @default.
• W4386779223 cites W2900348232 @default.
• W4386779223 cites W2904969803 @default.
• W4386779223 cites W2907049421 @default.
• W4386779223 cites W2951865926 @default.
• W4386779223 cites W2960783237 @default.
• W4386779223 cites W2975094970 @default.
• W4386779223 cites W2977883158 @default.
• W4386779223 cites W2997611592 @default.
• W4386779223 cites W3016542757 @default.
• W4386779223 cites W3022913130 @default.
• W4386779223 cites W3034725616 @default.
• W4386779223 cites W3038088150 @default.
• W4386779223 cites W3045030255 @default.
• W4386779223 cites W3045825841 @default.
• W4386779223 cites W3047302551 @default.
• W4386779223 cites W3048238297 @default.
• W4386779223 cites W3080519437 @default.
• W4386779223 cites W3083091393 @default.
• W4386779223 cites W3112951830 @default.
• W4386779223 cites W3115528239 @default.
• W4386779223 cites W3118412923 @default.
• W4386779223 cites W3121831652 @default.
• W4386779223 cites W3123894945 @default.
• W4386779223 cites W3124139149 @default.
• W4386779223 cites W3136180322 @default.
• W4386779223 cites W3137944655 @default.
• W4386779223 cites W3154783947 @default.
• W4386779223 cites W3159017041 @default.
• W4386779223 cites W3161034062 @default.
• W4386779223 cites W3161822520 @default.
• W4386779223 cites W3178151623 @default.
• W4386779223 cites W3178550118 @default.
• W4386779223 cites W3189750184 @default.
• W4386779223 cites W3191878299 @default.
• W4386779223 cites W3196404940 @default.
• W4386779223 cites W3198774415 @default.
• W4386779223 cites W3200136047 @default.
• W4386779223 cites W4210525365 @default.
• W4386779223 cites W4213231895 @default.
• W4386779223 cites W4214570861 @default.
• W4386779223 cites W4223484754 @default.
• W4386779223 cites W4223628420 @default.
• W4386779223 cites W4226139754 @default.
• W4386779223 cites W4226175268 @default.
• W4386779223 cites W4229793168 @default.
• W4386779223 cites W4289942227 @default.
• W4386779223 cites W4293105031 @default.
• W4386779223 cites W4293843069 @default.
• W4386779223 cites W4294925188 @default.
• W4386779223 cites W4306410058 @default.
• W4386779223 cites W4308308007 @default.
• W4386779223 cites W4323545999 @default.
• W4386779223 cites W4362542526 @default.
• W4386779223 cites W4379375798 @default.
• W4386779223 cites W4379518622 @default.
• W4386779223 doi "https://doi.org/10.1016/j.msard.2023.105009" @default.
• W4386779223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37783194" @default.

• next